International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7844634
Original Article
Perception of covid-19 vaccine in pregnant women
Published
April 19, 2023
Abstract
Background: Vaccine safety scares, whether factual or fabricated, can erode confidence and reduce coverage. Acceptance of vaccination during pregnancy is likely to raise specific questions and concerns among pregnant women. The effects of vaccination on the placenta and foetus and physiological changes in pregnancy make pregnant women a specific population that may respond differently to vaccination. These uncertainties must be considered in order to assess the benefit-risk balance and to make the most appropriate choice for pregnant patients at increased risk of severe COVID-19 [1]. Hence this study was conducted to study the prevalence of acceptance of COVID-19 vaccine in pregnant women and to find out hesitancy of COVID-19 vaccine in pregnant women. Methods: This Cross-sectional study was conducted among 83 Pregnant women by using Convenience Sampling method at Terna Medical Hospital. The questionnaire was prepared and validated. Participants were asked whether or not they would agree to be vaccinated against Covid 19 and why. Analysis was done by SPSS version (20.0) by applying chi square test. Results: 94% were aware about the existence of COVID 19 Vaccination and 93.9% accepted getting vaccinated against COVID 19. 6.1% didn’t agree for vaccination. The top three reasons for pregnant women to decline COVID-19 vaccination during pregnancy even if the vaccine were safe and free were that: 1.Do not want to expose their developing baby to any possible harmful side effect 2.afraid of side effects to themselves 3. Had insufficient knowledge about vaccine. Conclusion: To increase vaccine acceptance, locally-specific vaccine programs are needed in population. Vaccine education campaigns should emphasize the pandemic as a whole and its impact on communities, rather than limiting to vaccine safety and effectiveness.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2839 Views
306 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved